Let Canada’s #1 pharmacology text help guide you in mastering the complicated world of nursing pharmacology. Now in its fourth edition, Lilley’s Pharmacology for Canadian Health Care Practice covers all the key pharmacology content needed by today’s Canadian nurses. Known for its vibrant design, abundance of visuals, and wealth of helpful feature boxes, this engaging text brings important pharmacology concepts to life. The text’s popular and unique key drug approach focuses only on the drug information you need to know to safely and effectively administer drugs. Along with its exam preparation and insightful learning strategies, it’s the complete (and proven) pharmacology text to help you succeed in school, clinicals, and professional practice.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. About the Authors - p. v 6. Reviewers - p. vii 7. Preface - p. ix 8. Acknowledgements - p. xiii 9. PART 1. Pharmacology Basics - p. xiii 10. 1. Nursing Practice in Canada and Drug Therapy - p. 1 11. 2. Pharmacological Principles - p. 14 12. 3. Legal and Ethical Considerations - p. 36 13. 4. Patient-Focused Considerations - p. 47 14. 5. Gene Therapy and Pharmacogenomics - p. 67 15. 6. Medication Errors: Preventing and Responding - p. 75 16. 7. Patient Education and Drug Therapy - p. 88 17. 8. Over-the-Counter Drugs and Natural Health Products - p. 98 18. 9. Vitamins and Minerals - p. 111 19. 10. Principles of Drug Administration - p. 133 20. PART 2. Drugs Affecting the Central Nervous System - p. 163 21. 11. Analgesic Drugs - p. 164 22. 12. General and Local Anaesthetics - p. 195 23. 13. Central Nervous System Depressants and Muscle Relaxants - p. 214 24. 14. Central Nervous System Stimulants and Related Drugs - p. 228 25. 15. Antiepileptic Drugs - p. 244 26. 16. Antiparkinsonian Drugs - p. 262 27. 17. Psychotherapeutic Drugs - p. 278 28. 18. Substance Misuse - p. 308 29. PART 3. Drugs Affecting the Autonomic Nervous System - p. 324 30. 19. Adrenergic Drugs - p. 325 31. 20. Adrenergic-Blocking Drugs - p. 338 32. 21. Cholinergic Drugs - p. 350 33. 22. Cholinergic-Blocking Drugs - p. 361 34. PART 4. Drugs Affecting the Cardiovascular and Renal Systems - p. 370 35. 23. Antihypertensive Drugs - p. 371 36. 24. Antianginal Drugs - p. 394 37. 25. Heart Failure Drugs - p. 408 38. 26. Antidysrhythmic Drugs - p. 423 39. 27. Coagulation Modifier Drugs - p. 444 40. 28. Antilipemic Drugs - p. 469 41. 29. Diuretic Drugs - p. 485 42. 30. Fluids and Electrolytes - p. 500 43. PART 5. Drugs Affecting the Endocrine System - p. 518 44. 31. Pituitary Drugs - p. 519 45. 32. Thyroid and Antithyroid Drugs - p. 528 46. 33. Antidiabetic Drugs - p. 537 47. 34. Adrenal Drugs - p. 563 48. 35. Women’s Health Drugs - p. 574 49. 36. Men’s Health Drugs∗ - p. 596 50. PART 6. Drugs Affecting the Respiratory System - p. 605 51. 37. Antihistamines, Decongestants, Antitussives, and Expectorants - p. 606 52. 38. Respiratory Drugs - p. 621 53. PART 7. Drugs Affecting the Gastrointestinal System and Nutrition - p. 639 54. 39. Acid-Controlling Drugs - p. 640 55. 40. Antidiarrheal Drugs and Laxatives - p. 654 56. 41. Antiemetic and Antinausea Drugs - p. 667 57. 42. Nutritional Supplements - p. 679 58. PART 8. Anti-infective and Anti-inflammatory Drugs - p. 690 59. 43. Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines - p. 691 60. 44. Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs - p. 715 61. 45. Antiviral Drugs - p. 731 62. 46. Antitubercular Drugs - p. 753 63. 47. Antifungal Drugs - p. 764 64. 48. Antimalarial, Antiprotozoal, and Anthelmintic Drugs - p. 774 65. 49. Anti-inflammatory and Antigout Drugs - p. 789 66. PART 9. Immune and Biological Modifiers and Chemotherapeutic Drugs - p. 803 67. 50. Immunosuppressant Drugs - p. 804 68. 51. Immunizing Drugs and Pandemic Preparedness - p. 815 69. 52. Antineoplastic Drugs Part 1: Cancer Overview and CellCycle–Specific Drugs - p. 832 70. 53. Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs - p. 859 71. 54. Biological Response–Modifying Drugs and Antirheumatic Drugs - p. 872 72. PART 10. Miscellaneous Therapeutics: Hematological, Dermatological, Ophthalmic, and Otic Drugs - p. 891 73. 55. Anemia Drugs - p. 892 74. 56. Dermatological Drugs - p. 903 75. 57. Ophthalmic Drugs - p. 918 76. 58. Otic Drugs - p. 939 77. Appendix. Pharmaceutical Abbreviations - p. 945 78. Answers to Review Questions - p. 946 79. Bibliography - p. 949 80. Index of Glossary Terms - p. 966 81. Drug Index - p. 973 82. General Index - p. 981 83. Special Features - p. 1017
Let Canada’s #1 pharmacology text help guide you in mastering the complicated world of nursing pharmacology. Now in its fourth edition, Lilley’s Pharmacology for Canadian Health Care Practice covers all the key pharmacology content needed by today’s Canadian nurses. Known for its vibrant design, abundance of visuals, and wealth of helpful feature boxes, this engaging text brings important pharmacology concepts to life. The text’s popular and unique key drug approach focuses only on the drug information you need to know to safely and effectively administer drugs. Along with its exam preparation and insightful learning strategies, it’s the complete (and proven) pharmacology text to help you succeed in school, clinicals, and professional practice.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. About the Authors - p. v 6. Reviewers - p. vii 7. Preface - p. ix 8. Acknowledgements - p. xiii 9. PART 1. Pharmacology Basics - p. xiii 10. 1. Nursing Practice in Canada and Drug Therapy - p. 1 11. 2. Pharmacological Principles - p. 14 12. 3. Legal and Ethical Considerations - p. 36 13. 4. Patient-Focused Considerations - p. 47 14. 5. Gene Therapy and Pharmacogenomics - p. 67 15. 6. Medication Errors: Preventing and Responding - p. 75 16. 7. Patient Education and Drug Therapy - p. 88 17. 8. Over-the-Counter Drugs and Natural Health Products - p. 98 18. 9. Vitamins and Minerals - p. 111 19. 10. Principles of Drug Administration - p. 133 20. PART 2. Drugs Affecting the Central Nervous System - p. 163 21. 11. Analgesic Drugs - p. 164 22. 12. General and Local Anaesthetics - p. 195 23. 13. Central Nervous System Depressants and Muscle Relaxants - p. 214 24. 14. Central Nervous System Stimulants and Related Drugs - p. 228 25. 15. Antiepileptic Drugs - p. 244 26. 16. Antiparkinsonian Drugs - p. 262 27. 17. Psychotherapeutic Drugs - p. 278 28. 18. Substance Misuse - p. 308 29. PART 3. Drugs Affecting the Autonomic Nervous System - p. 324 30. 19. Adrenergic Drugs - p. 325 31. 20. Adrenergic-Blocking Drugs - p. 338 32. 21. Cholinergic Drugs - p. 350 33. 22. Cholinergic-Blocking Drugs - p. 361 34. PART 4. Drugs Affecting the Cardiovascular and Renal Systems - p. 370 35. 23. Antihypertensive Drugs - p. 371 36. 24. Antianginal Drugs - p. 394 37. 25. Heart Failure Drugs - p. 408 38. 26. Antidysrhythmic Drugs - p. 423 39. 27. Coagulation Modifier Drugs - p. 444 40. 28. Antilipemic Drugs - p. 469 41. 29. Diuretic Drugs - p. 485 42. 30. Fluids and Electrolytes - p. 500 43. PART 5. Drugs Affecting the Endocrine System - p. 518 44. 31. Pituitary Drugs - p. 519 45. 32. Thyroid and Antithyroid Drugs - p. 528 46. 33. Antidiabetic Drugs - p. 537 47. 34. Adrenal Drugs - p. 563 48. 35. Women’s Health Drugs - p. 574 49. 36. Men’s Health Drugs∗ - p. 596 50. PART 6. Drugs Affecting the Respiratory System - p. 605 51. 37. Antihistamines, Decongestants, Antitussives, and Expectorants - p. 606 52. 38. Respiratory Drugs - p. 621 53. PART 7. Drugs Affecting the Gastrointestinal System and Nutrition - p. 639 54. 39. Acid-Controlling Drugs - p. 640 55. 40. Antidiarrheal Drugs and Laxatives - p. 654 56. 41. Antiemetic and Antinausea Drugs - p. 667 57. 42. Nutritional Supplements - p. 679 58. PART 8. Anti-infective and Anti-inflammatory Drugs - p. 690 59. 43. Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines - p. 691 60. 44. Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs - p. 715 61. 45. Antiviral Drugs - p. 731 62. 46. Antitubercular Drugs - p. 753 63. 47. Antifungal Drugs - p. 764 64. 48. Antimalarial, Antiprotozoal, and Anthelmintic Drugs - p. 774 65. 49. Anti-inflammatory and Antigout Drugs - p. 789 66. PART 9. Immune and Biological Modifiers and Chemotherapeutic Drugs - p. 803 67. 50. Immunosuppressant Drugs - p. 804 68. 51. Immunizing Drugs and Pandemic Preparedness - p. 815 69. 52. Antineoplastic Drugs Part 1: Cancer Overview and CellCycle–Specific Drugs - p. 832 70. 53. Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs - p. 859 71. 54. Biological Response–Modifying Drugs and Antirheumatic Drugs - p. 872 72. PART 10. Miscellaneous Therapeutics: Hematological, Dermatological, Ophthalmic, and Otic Drugs - p. 891 73. 55. Anemia Drugs - p. 892 74. 56. Dermatological Drugs - p. 903 75. 57. Ophthalmic Drugs - p. 918 76. 58. Otic Drugs - p. 939 77. Appendix. Pharmaceutical Abbreviations - p. 945 78. Answers to Review Questions - p. 946 79. Bibliography - p. 949 80. Index of Glossary Terms - p. 966 81. Drug Index - p. 973 82. General Index - p. 981 83. Special Features - p. 1017
